M&A Archives - Page 33 of 448

2 minute read

What’s Going On With Bentley Systems Stock Amid Multibillion-Dollar Merger Talks?

April 19, 8:44 AM

Schneider Electric and Bentley Systems are in talks, hinting at a major shift in engineering software. The French industrial leader eyes Bentley's renowned solutions, with a potential merger valued at over $15 billion,. Despite uncertainties, this move underscores Schneider's strategic drive, echoing its history of aggressive acquisitions to fortify its software arm against industry titans.

BSY

1 minute read

Burke & Herbert Financial Services Corp. And Summit Financial Group, Inc. Announce Receipt Of Regulatory Approvals And Closing Date Of May 3, 2024 For Merger Of Equals

By Benzinga Newsdesk

April 19, 8:34 AM

Burke & Herbert Annual Shareholder Meeting Date EstablishedALEXANDRIA, Va. and MOOREFIELD, W.Va., April 19, 2024 /PRNewswire/ -- Burke & Herbert Financial Services Corp. ("Burke & Herbert") (NASDAQ:BHRB)

BHRB

2 minute read

Glacier Bancorp, Inc. Receives Regulatory Approval For Acquisition Of Six Montana Branches From HTLF Bank; Transaction Is Projected To Be ~$0.03 Per Share, Or 1.6%, Accretive To Glacier’s 2024 Estimated EPS, Given The Expected Partial Year Impact And E…

By Benzinga Newsdesk

April 18, 4:41 PM

Glacier Bancorp, Inc. (NYSE:GBCI) today announced that its banking subsidiary, Glacier Bank, has received all regulatory approvals required to complete its previously announced acquisition of six Montana branch locations

GBCI

2 minute read

German Authority Gives Go Ahead To Novo Nordisk’s Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline

By Vandana Singh

April 18, 1:55 PM

Novo Nordisk's acquisition of Cardior Pharmaceuticals clears regulatory hurdles, advancing cardiovascular treatment development with CDR132L. Learn about the promising phase 2 trials and strategic expansion. Deal expected to close Q2 2024.

NVO

2 minute read

Once Valued At Billions, 23andMe’s CEO Considers Privatization To Secure Company’s Future

By Vandana Singh

April 18, 12:06 PM

Anne Wojcicki, CEO of 23andMe mulls taking the genetics company private amid market challenges. With declining revenue and a focus shift to drug development, the move seeks funding for potential breakthroughs.

GSK

2 minute read

Rio Tinto, Saudi’s Manara Emerge As Likely Bidders For First Quantum’s Zambian Assets: Report

By Stjepan Kalinic

April 18, 11:39 AM

Rio Tinto, Manara, Mitsui & Co. and Sumitomo Corp. are rumored to be circling First Quantum-owned assets currently for sale.

FQVLF

2 minute read

AiBtl BioPharma Inc. Acquired TT Life Company, Valued At $8.33M, With 1.66M AiBtl Shares At $5 per Share

By Benzinga Newsdesk

April 18, 9:26 AM

ABVC BioPharma, Inc. (NASDAQ:ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and Oncology/Hematology, announced today that

ABVC

1 minute read

Stellantis Charges Up With $100M Solar Investment in Argentina: Report

By Lekha Gupta

April 18, 7:56 AM

Stellantis reportedly plans to acquire 49.5% of 360 Energy Solar for $100 million in Argentina to increase renewable energy at its plants, including powering them with 360's solar power plant.

STLA

2 minute read

Thoughtworks Acquires Technology And Talent From Watchful; Financial Terms Were Not Disclosed

By Benzinga Newsdesk

April 17, 4:35 PM

Thoughtworks (NASDAQ:TWKS), a global technology consultancy that integrates strategy, design and engineering, is pleased to announce the successful acquisition of the talented individuals and technology assets from

TWKS

3 minute read

Xtract One Announces Marketed Public Offering Of Units And Concurrent Investment By MSG Sports Ventures, A Wholly-Owned Subsidiary Of Madison Square Garden Sports Corp.

By Benzinga Newsdesk

April 17, 4:31 PM

Xtract One Technologies Inc. (TSX:XTRA) (OTCQX:XTRAF) (FRA: 0PL) ("Xtract One" or the "Company") is pleased to announce that it has entered into an engagement letter with Eight Capital (the "Agent") pursuant to which the

MSGS